Abstract: The present disclosure provides small molecule drugs and pharmaceutical compositions for the treatment and prevention of diseases related to the formation of A?42 oligomers in a subject. It further provides a method of reducing formation of or disrupting A?42 oligomers in a subject, the method comprising the step of administering to the subject in need thereof a therapeutically effective amount of a pharmaceutical composition.

Abstract: The present invention concerns a pharmaceutically acceptable salt of a compound of the following formula (I): H2N—CH(R1)—CH2S—S—CH2—CH(R2—CONH—CH(R3)—COOR4 (I) and more particularly an acid addition salt thereof, and the compositions comprising the same, for use in the prevention or treatment of trigeminal nerve pain, in particular migraines or trigeminal neuralgia.

Abstract: Disclosed are an ionic liquid, having wear resistance maintained at low temperatures and containing a divalent cation including at least one of bis(ammonium) and bis(phosphonium) and a monovalent anion including at least one of sulfonate and phosphate, and a lubricant composition including the ionic liquid.

Abstract: The present invention provides a process for preparation of trientine dihydrochloride (1) comprising reaction of protected triethylene tetramine with hydrochloric acid in an aqueous system to yield the dihydrochloride salt wherein the formation of inorganic impurities and undesired salts is controlled significantly.

Abstract: Low molecular weight gelators, methods of making such gelators, organogels comprising such gelators and methods of using such organogels are described. In exemplary methods, the gelators can be used in a variety of applications including the delivery of pharmaceutical active pharmaceutical ingredients, in food, cosmetics and consumer products, and in containing the unexpected release of chemical that occur for example in spills.

Abstract: Biocidal compositions and their use in aqueous media, such as metalworking fluids, the compositions comprising a biocidal agent; and a non-biocidal primary amino alcohol compound of the formula (I); wherein R1, R2, R3, R4, and R5 are as defined herein.

Abstract: Treatment compositions for neutralizing acidic species and reducing hydrochloride and amine salts in a fluid hydrocarbon stream are disclosed. The treatment compositions may comprise at least one amine with a salt precipitation potential index of equal to or less than about 1.0. Methods for neutralizing acidic species and reducing deposits of hydrochloride and amine salts in a hydrocarbon refining process are also disclosed. The methods may comprise providing a fluid hydrocarbon stream and adding a treatment composition to the fluid hydrocarbon stream. The treatment compositions used may have a salt precipitation potential index of equal to or less than about 1.0 and comprise either water-soluble or oil-soluble amines.

Abstract: Basic esters of fatty alcohols of the general formula: R1-O—CO-A or pharmaceutically acceptable salts thereof, wherein R1 is C12-C24 alkyl or C10-C24 alkenyl, and A is a residue containing at least one acyclic or cyclic amino group and/or at least one heteroaromatic ring containing a tertiary or quaternary nitrogen atom, are anti-inflammatory and immunomodulatory agents, useful in the treatment of immunologically-mediated inflammation, as adjuvants for antigens involved in both cellular and humoral responses.

Abstract: A method for producing nitrous acid ester in which nitric oxide, oxygen, and an alcohol are reacted, thereby generating nitrous acid ester includes a step of generating nitrous acid ester by supplying a bottom liquid from a bottom part of the reaction column, and nitric oxide and/or carbon monoxide, a step of supplying nitrous acid ester to the reaction column; a step of supplying a reaction liquid containing water, nitric acid, and the alcohol to a nitric acid condensing column from the reactor; and a step of separating a low-boiling point component by distillation from the reaction liquid under control of a concentration of the alcohol in a condensed liquid being generated at a bottom part of the nitric acid condensing column to be less than 4.0% by weight so as to introduce the condensed liquid into the reactor from the nitric acid condensing column.

Abstract: The invention relates to a method for reducing the concentration of amines and salts thereof, wherein the amines have the general chemical formula I R1R2R3N and the salts have the formula II R1R2R3N—H, wherein the amines and salts thereof exist in aqueous solution or aqueous suspension and are brought into contact with clinoptilolitic or clinoptilolite-containing mixtures. The method itself is suitable for use in food preparation and in the manufacture of foods. The inventive idea of reducing the concentration of amines and salts thereof is also useful in the manufacture of medical products for absorbing and for removing amines from the intestinal tract or the skin area of humans and animals.

Abstract: A process for producing N-methyl or N,N-dimethyl amines, which comprises using amine compound, nitro-containing compound or nitrile compound as a starting material, carbon dioxide as a methylating agent and hydrogen gas as a reducing agent, and allowing them to react in a sealed reactor for 6 to 48 h in a reaction medium at a reaction temperature of 80 to 180 ° C. in the presence of a composite catalyst, so as to provide N-methyl or N,N-dimethyl amines. The process of the present invention is simple and under relative mild reaction conditions. By means of the process of the invention, the target products can be prepared at low cost with a high yield. The catalysts used have a high catalytic activity and can be separated from the reaction system simply and reused. Furthermore, the whole process of the present invention is environmental-friendly and facilitates the cycling use of carbon dioxide.

Abstract: The present invention relates to a method of producing a carbamate compound, comprising reacting a fluorine-containing carbonic diester compound represented by formula (1) and a non-aromatic diamine compound represented by formula (2) without using a catalyst, to thereby produce a carbamate compound represented by formula (3), and a method of producing an isocyanate compound represented by formula (20) from the carbamate compound without using a catalyst, wherein R represents a fluorine-containing monovalent aliphatic hydrocarbon group, and A represents a divalent aliphatic hydrocarbon group, a divalent alicyclic hydrocarbon group or a divalent aromatic-aliphatic hydrocarbon group.

Abstract: The invention provides a novel process for the synthesis of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one, the process comprising of reacting the salicylic acid with salicylamide in the presence of p-toluenesulfonyl chloride, base and solvent. The use of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one in the preparation of Deferasirox is also disclosed in the invention.

Abstract: To provide a CxNyHz film of high density and a deposition method. One aspect of the present invention is a CxNyHz film formed on a substrate to be deposited, wherein x, y and z satisfy formulae (1) to (4) below: 0.4<x<0.7??(1) 0.01<y<0.5??(2) 0?z<0.3??(3) x+y+z=1.

Abstract: A polymeric composition that includes at least one polymer and an effective amount of a nanoparticulate component. The nanoparticulate component is at least one of inorganic functional nanoparticulate compounds and graphene in which the nanoparticulate component is associated with the polymer. The polymer disclosed herein can have electromagnetic activity. The resulting polymeric composition exhibit a measurable electrical conductivity (?) range of 10?14 to 4.7*106 (S/m) at 20° C. A polymeric precursor that includes at least one component selected from the group that includes isocyanates, polyisocyanates, MDI-terminated prepolymers and an effective amount of a nanoparticulate component. The nanoparticulate component is at least one of inorganic functional nanoparticulate component being at least one of inorganic functional nanoparticulate compounds and graphene that is associated with the prepolymer.

Abstract: The present application provides methods for decarboxylation of amino acids via imine formation with a catalyst under superheated conditions in either a microwave or oil bath.

Abstract: A process for making a 2-nitro-1-ethanol derivative of formula III: wherein R3 is as described herein is provided. Novel 2-nitro-1-ethanol derivatives provided.

Abstract: Disclosed is a method for producing “a salt or a complex comprising imide and an organic base”, characterized by reacting halogenated sulfuryl or halogenated phosphoryl with ammonia in the presence of an organic base. According to this method, a target imide compound can be produced in a high yield while significantly suppressing the production of by-products. Further, by reacting the obtained imide compound with an alkali metal hydroxide or an alkaline earth metal hydroxide, an imide metal salt can be easily derived.

Abstract: Method for storing a gas in solid phase so that it can be distributed in gaseous phase, that consists in introducing the gas in gaseous phase into a storage tank (1) containing a reactive mixture the apparent density of which is between 40 kg/m3 and 60 kg/m3 and preferably of the order of 50 kg/m3, and which is made up of a reactive product and of expanded natural graphite, this reactive mixture and the gas being such that, when brought into the presence of one another, the reactive product and the gas undergo a thermochemical reaction the effect of which is that the gas is absorbed by the reactive product and a solid product of reaction is produced and, conversely, undergo a reverse thermochemical reaction in which the gas absorbed by the reactive product is desorbed when this product is heated after it has absorbed the gas.

Abstract: The present invention relates to a process comprising adding a sufficient amount of a halamine with a latex binder to achieve microbial prophylaxis, wherein the halamine is characterized by the following formula: wherein X1 is H, Br, or Cl; X2 is Br or Cl; and R1 is H or a C1-30 alkyl group or mixtures thereof. The present invention also relates to a composition comprising the halamine and a latex binder. The present invention provides a quick kill shelf stable preservative for latex binders and for formulations that use such binders.

Abstract: The present invention provides a chemically functionalized submicron graphitic fibril having a diameter or thickness less than 1 ?m, wherein the fibril is free of continuous thermal carbon overcoat, free of continuous hollow core, and free of catalyst. The fibril is obtained by splitting a micron-scaled carbon fiber or graphite fiber along the fiber axis direction. These functionalized graphitic fibrils exhibit exceptionally high electrical conductivity, high thermal conductivity, high elastic modulus, high strength and good interfacial bonding with a matrix resin in a composite. The present invention also provides several products that contain submicron graphitic fibrils: (a) paper, thin-film, mat, and web products; (b) rubber or tire products; (c) energy conversion or storage devices, such as fuel cells, lithium-ion batteries, and supercapacitors; (d) adhesives, inks, coatings, paints, lubricants, and grease products; (e) heavy metal ion scavenger; (f) absorbent (e.g.

Abstract: The present application relates to surfactant compositions comprising a) at least one phosphated arylphenol alkoxylate surfactant having an average degree of alkoxylation of from 4-8; and b) at least one alkylamine alkoxylate surfactant having an average degree of alkoxylation of from 2-12 and to the use of these compositions in pesticide formulations comprising solid or encapsulated pesticidally active ingredients or formulation aids and methods for improving the re-suspension properties of pesticide suspensions.

Abstract: Provided are a functional-group-modified carbon material modified with an isocyanate group or amino group, and a method for producing the material. The material is an isocyanate-group-modified carbon material in which an isocyanate group of a diisocyanate compound is bonded to a graphene-like carbon material, or an amino-group-modified carbon material in which a fragment obtained by radical-decomposing an amino-group-containing azo-type radical initiator is added to the graphene-like carbon material by radical-trapping. The method is a method for producing a functional-group-modified carbon material, including heating and stirring, in a solvent, a graphene-like carbon material, and a diisocyanate compound or an amino-group-containing azo-type radical initiator.

Abstract: The present invention relates to a process for deuteration of amines in the alpha and/or beta position of the N-atom by using a deuterium source and a Ruthenium(II) based catalyst.

Abstract: The invention discloses a compound having branching alkyl chains, the method for preparing the same and use thereof in photoelectric devices. By applying the branching alkyl chains as the solubilizing group to the preparation of organic conjugated molecules (for example, organic conjugated polymers), the number of methylenes between the resultant alky side chains and the backbone, i.e., m>1, which can effectively reduce the effect of the alkyl chains on the backbone ?-? stacking, thereby ensuring the solubility of the organic conjugated molecule while greatly increasing the mobility of their carriers. It is suitable for an organic semiconductor material in photoelectric devices such as organic solar cells, organic light emitting diodes and organic field effect transistors, etc.

Abstract: The invention provides a novel process for the synthesis of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one, the process comprising of reacting the salicylic acid with salicylamide in the presence of p-toluenesulfonyl chloride, base and solvent. The use of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one in the preparation of Deferasirox is also disclosed in the invention.

Abstract: Treatment compositions for neutralizing acidic species and reducing hydrochloride and amine salts in a fluid hydrocarbon stream are disclosed. The treatment compositions may comprise at least one amine with a salt precipitation potential index of equal to or less than about 1.0. Methods for neutralizing acidic species and reducing deposits of hydrochloride and amine salts in a hydrocarbon refining process are also disclosed. The methods may comprise providing a fluid hydrocarbon stream and adding a treatment composition to the fluid hydrocarbon stream. The treatment compositions used may have a salt precipitation potential index of equal to or less than about 1.0 and comprise either water-soluble or oil-soluble amines.

Abstract: A process continuously hydrogenating unsaturated compounds, in which particles of a first hydrogenation catalyst are suspended in a liquid phase in which an unsaturated compound is dissolved, the liquid phase, in the presence of a hydrogenous gas at a first partial hydrogen pressure and at a first temperature, is conducted through a packed bubble column reactor in cocurrent counter to the direction of gravity, the effluent from the bubble column reactor is sent to a gas-liquid separation, the liquid phase is sent to a crossfiltration to obtain a retentate and a filtrate, the retentate is recycled into the bubble column reactor and the filtrate, in the presence of a hydrogenous gas at a second partial hydrogen pressure and at a second temperature, is passed over a bed of a second hydrogenation catalyst, the second partial hydrogen pressure is at least 10 bar higher than the first partial hydrogen pressure.

Abstract: A composition and method for treatment of cancer. The composition for treating a skin disorder, comprising: an alkylating agent such as, for example, a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, wherein the alkylating agent is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol does not include petrolatum or ethanol. The method comprises topically applying the composition of the alkylating agent to the affected skin, wherein the alkylating agent is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol.

Abstract: Process for preparing tri-n-propylamine (TPA), wherein di-n-propylamine (DPA) is reacted in the presence of hydrogen and a copper-comprising heterogeneous catalyst. An integrated process for preparing TPA, which comprises the following operations: I) reaction of n-propanol with ammonia in a reactor in the presence of an amination catalyst and optionally hydrogen to form a mixture of mono-n-propylamine, DPA and TPA, II) separation of unreacted ammonia, unreacted n-propanol and possibly hydrogen from the reaction product mixture and recirculation of at least the ammonia and propanol to the reactor in I) and also separation of the n-propylamine mixture by distillation and isolation of the TPA, III) reaction of the DPA obtained in the separation by distillation in II) in a reactor in the presence of hydrogen and a copper-comprising heterogeneous catalyst to form TPA and IV) feeding of the reactor output from III) to operation II).

Abstract: Process for the preparation of polyalkylenepolyamines by homogeneously catalyzed alcohol amination, in which aliphatic amino alcohols are reacted with one another or aliphatic diamines or polyamines are reacted with aliphatic diols or polyols with the elimination of water in the presence of a homogeneous catalyst and in the presence of hydrogen gas. Polyalkylenepolyamines obtainable by such processes and polyalkylenepolyamines comprising hydroxy groups, secondary amines or tertiary amines. Uses of such polyalkylenepolyamines as adhesion promoters for printing inks, adhesion promoters in composite films, cohesion promoters for adhesives, crosslinkers/curing agents for resins, primers for paints, wet-adhesion promoters for emulsion paints, complexing agents and flocculating agents, penetration assistants in wood preservation, corrosion inhibitors, immobilizing agents for proteins and enzymes.

Abstract: This invention relates to a process for working up residues from production of isocyanates. This process involves hydrolyzing residues from production of at least one isocyanate with water to form a hydrolysis product, and processing the hydrolysis product within an extruder or a kneader having a heat transfer surface, to form a mixed product containing at least one amine and water. The amine and the water are separated from the mixed product to form an amine/water mixture, which is then separated to obtain the water and the amine. The process may also involve separating all or part of the water from the hydrolysis, or separating part of the amine from the hydrolysis, prior to the processing of the hydrolysis product.

Abstract: The invention relates to the use of valnoctamide (VCD) for the treatment of bipolar disorder and in particular for the treatment of the manic phase of the bipolar disorder.

Abstract: A crystalline molecular sieve comprises at least [AlO4] and [PO4] tetrahedral units and comprising a first framework structure defining a first set of uniformly distributed pores having an average cross-sectional dimension of from about 0.3 to less than 2 nanometers and further comprising a second framework structure defining a second set of uniformly distributed pores having an average cross-sectional dimension of from 2 to 50 nanometers. The first framework structure is preferably of the CHA framework type.

Abstract: An amphiphilic nanoparticle comprises a nanoparticle having a hydrophilic region comprising a hydrophilic functional group bonded to a first portion of a surface of the nanoparticle, and a hydrophobic region of a surface of the nanoparticle. A downhole fluid comprises the amphiphilic nanoparticle, and a method of controlling an oil spill using the downhole fluid are also disclosed.

Abstract: The present invention relates to a binder for the production of bonded mineral wool, wherein a phenol-formaldehyde-binder is applied onto the still hot fibers after the fiberization of a mineral wool, using a binder that comprises hydroxylamine or an amino alcohol with the following general formula (I) wherein R1 and R2 are the same or different from each other, and independently are hydrogen, a linear or branched, saturated or unsaturated aliphatic hydrocarbon with 1-12 carbon atoms, a saturated or unsaturated alicyclic or heterocyclic hydrocarbon with 5-8 carbon atoms, a carbocyclic or heterocyclic aromatic hydrocarbon with 5-12 ring members or a chain-like or branched alkylether with 1-50 alkoxy units or a chain-like or branched alkylamine with 1-50 alkylamine units; and R3 is a linear or branched, saturated or unsaturated aliphatic hydrocarbon with 1-12 carbon atoms, a saturated or unsaturated alicyclic or heterocyclic hydrocarbon with 5-8 carbon atoms, a carbocyclic or heterocyclic aromatic hydrocarbon w

Abstract: Methods of applying cyclopropene amine derivatives and compositions thereof to inhibit ethylene receptors in plants and plant material are disclosed. Methods include applying to the plant an effective ethylene response-inhibiting amount of at least one cyclopropene amine compound or composition thereof. Cyclopropene amine compounds, enantiomers, stereoisomers or salts thereof are also provided.

Abstract: An isotope-doped nano-structure is provided. The isotope-doped nano-structure includes at least one isotope-doped nano-structure segment having at least two isotopes of the element. The at least two isotopes of the element are mixed uniformly in a certain proportion. The isotope-doped nano-structure can be used for isotope labeling one type of the unlabeled structures such as DNAs, proteins, glucoses, gluconic acids, starches, biotin enzymes, sorbitols, or organic amines. An isotope labeled structure is also provided.

Abstract: Use of compounds of molecular formula (I) as curing activators of mixes having a cross-linkable unsaturated-chain polymer base: ([R1R2R3NR5(NR4R6R7)n](n+1)+)y (n+1)Xy? (I); where: X is an anionic atom or group; R1, R2 and R3, which may be the same or different, are each CmH2m+1, where m ranges between 1 and 3, or CH2CHCH2 or CHCHCH3; R4, R6 and R7, which may be the same or different, are each CH2CHCH2 or CHCHCH3; n is 0 or 1; y is 1 when n is 1; y is 1 or 2 when n is 0; R5 is an aliphatic group C15-C22 when n is 0; and is an aliphatic group C8-C16 when n is 1; when n is 0, at least one of R1, R2, R3 and R5 comprises a double bond.

Abstract: An extraction method for extracts of Geranium or Pelargonium with improved methylhexaneamine content is provided. The method involves separating the oil phase from the aqueous phase; concentrating the aqueous phase; purifying the oil phase; and recombining the resulting material. Additionally, extracts of Geranium or Pelargonium prepared by the extraction method are provided. The extracts are useful in compositions, for example as dietary supplements, and for appetite suppression.

Abstract: The invention relates to novel compounds of formula (I): H2N—CH(R1)—CH2—S—S—CH2—CH(R2)—CONH—R5, wherein R1 is a hydrocarbon chain, phenyl or benzyl radical, methylene radical substituted by a 5 or 6 atom heterocycle; R2 is a phenyl or benzyl radical, a 5 or 6 atom aromatic heterocycle, methylene group substituted by a 5 or 6 atom heterocycle; R5 is a CH(R3)—COOR4 radical, wherein R3 is hydrogen, an OH or OR group, a saturated hydrocarbon group, a phenyl or benzyl radical and OR4 is hydrophile ester, or 5 or 6 membered heterocycle comprising several heteroatoms selected from a group consisting of nitrogen, sulphur and oxygen, with at least two nitrogene atoms, wherein said heterocycle is substitutable by an alkyl C1-C6, phenyl or benzyl radical.

Abstract: The invention relates to novel compounds of formula (I): H2N—CH(R1)—CH2—S—S—CH2—CH(R2)—CONH—R5, wherein R1 is a hydrocarbon chain, phenyl or benzyl radical, methylene radical substituted by a 5 or 6 atom heterocycle; R2 is a phenyl or benzyl radical, a 5 or 6 atom aromatic heterocycle, methylene group substituted by a 5 or 6 atom heterocycle; R5 is a CH(R3)—COOR4 radical, wherein R3 is hydrogen, an OH or OR group, a saturated hydrocarbon group, a phenyl or benzyl radical and OR4 is hydrophile ester, or 5 or 6 membered heterocycle comprising several heteroatoms selected from a group consisting of nitrogen, sulphur and oxygen, with at least two nitrogene atoms, wherein said heterocycle is substitutable by an alkyl C1-C6, phenyl or benzyl radical.

Abstract: Provided is a low-cost, highly active, environmentally friendly living radical polymerization catalyst which does not require a radical initiator. An organic compound having an oxidation-reduction capability is used as a catalyst. Even if a radical initiator is not used, a monomer can be subjected to a radical polymerization to obtain a polymer having narrow molecular weight distribution. The cost of the living radical polymerization can be remarkably reduced. It is made possible to prevent adverse effects of using a radical initiator. The present invention is significantly more environmentally friendly and economically excellent than conventional living radical polymerization methods, due to advantages of the catalyst such as low toxicity of the catalyst, low amount of the catalyst necessary, high solubility of the catalyst, mild reaction conditions, and no coloration/no odor (which do not require a post-treatment for a molded article), etc.

Abstract: The present invention provides a method for producing chiral amines, comprising asymmetric transfer hydrogenation of imine compounds in the presence of a hydrogen donor compound and an iridium(III) complex having a chiral prolinamide compound as a ligand. The present invention is useful for production of chiral amines in an efficient manner in terms of their optical and chemical yields.

Abstract: EMM-11 is a novel synthetic crystalline microporous material having a single crystalline phase with a unique 3-dimensional channel system comprising three sets of channels, namely a first set comprising 10-ring channels, and a second set and third set comprising 8-ring channels, having a unique T-atom connectivity and X-ray diffraction pattern which identify it as a novel material, and may be prepared with an organic structure directing agent, preferably, 3-isopropyl-1-methyl-1H-imidazol-3-ium. EMM-11 may be used in organic compounds conversion and absorptive processes.

Abstract: The present invention is aimed to provide a method for industrially producing a useful substance (protein etc.) utilizing a bacterium such as Escherichia coli in the presence of a surfactant and a surfactant to be used in this method for producing a useful substance. The present invention is a method for producing a useful substance into a culture solution by secretion by a bacterium in the culture solution, wherein the culture solution contains a surfactant (A), and a dried cell density based on the volume of the culture solution is 1.5 to 500 g/L. More preferably, the present invention is a method for producing a useful substance wherein the surfactant (A) is at least one agent selected from the group consisting of an amphoteric surfactant, an anionic surfactant, and a nonionic surfactant having an HLB value of 0 to 13.

Abstract: The present invention relates to diionic liquid salts of dicationic or dianionic molecules, as well as solvents comprising such diionic liquids and the use of such diionic liquids as the stationary phase in a gas chromatographic column.

Abstract: A method of producing NH2(R2), the method comprising reacting a metal hydride with a compound having the general formula: M1X(BH4)y(NH2(R2))n wherein M1 comprises one or more of Li, Na, K, Rb, Cs, Be, Mg, Ca, Sr, Ba, La, Al, Ga and Sc; 0<n?4; R2 comprises —H, alkyl and an aromatic substituent; and x and y are selected so as to maintain electroneutrality.

Abstract: A method of inhibiting gas hydrate formation in petroleum and natural gas production systems through the use of low dosage hydrate inhibitors which include reaction products of non-halide-containing inorganic acids, organic acids, and organic amines. The use of these non-halide-containing reaction products rather than chloride containing acids or alkylating agents avoids corrosion and stress cracking caused by residual inorganic chloride and other inorganic, halide-containing acids. The anti-agglomerate compositions can be administered continuously to effectively inhibit gas hydrate formation. In preferred embodiments, the anti-agglomerate compositions are mixtures of reaction products of non-halide-containing organic acids and organic amines.

Abstract: The present application relates to mixed Mg/Li amides of the general formula R1R2N—Mg(NR3R4)mX,.